Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $3.0k | 2.0k | 1.50 |
| 2025-06-30 | $2.2M | 1.7M | 1.29 |
| 2025-03-31 | $2.0M | 1.7M | 1.15 |
| 2024-12-31 | $2.1M | 2.0M | 1.06 |
| 2024-09-30 | $3.6M | 3.1M | 1.17 |
| 2024-06-30 | $3.9M | 3.7M | 1.08 |
| 2024-03-31 | $3.8M | 4.0M | 0.94 |
| 2023-12-31 | $2.1M | 2.2M | 0.98 |
| 2023-09-30 | $2.6M | 2.8M | 0.92 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1